Association of longer-term versus shorter-term antihypertensives prescriptions and clinical outcomes in patients with hypertension: A population-based propensity score matching study.

IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Tao Huang, Lin Bai, Huangqianyu Li, Peng Shen, Hongbo Lin, Hao Li, Zhiyuan Wang, Yang Xu, Luwen Shi, Xiaodong Guan
{"title":"Association of longer-term versus shorter-term antihypertensives prescriptions and clinical outcomes in patients with hypertension: A population-based propensity score matching study.","authors":"Tao Huang, Lin Bai, Huangqianyu Li, Peng Shen, Hongbo Lin, Hao Li, Zhiyuan Wang, Yang Xu, Luwen Shi, Xiaodong Guan","doi":"10.1016/j.sapharm.2025.08.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies have shown that longer-term prescriptions could improve medication adherence of patients with chronic diseases. However, no evidence demonstrated the impact of a longer supply duration on patients' clinical outcomes. The objective is to estimate the association between longer-term prescriptions with patients' clinical outcomes.</p><p><strong>Methods: </strong>A retrospective population-based propensity score-matched cohort study was conducted on the Chinese Electronic Health Records Research in Yinzhou database between January 2017 and June 2022. Prescriptions with the supply duration of antihypertensives >28 days were considered as longer-term prescriptions. The primary outcome was hospitalization for cardiovascular diseases. Secondary outcomes included medication adherence measured by medication possession ratio ≥80 % and visit frequency during the follow-up. Cox proportional hazard model and conditional logistic regression were used to estimate effects in the censored at treatment switch or discontinuation analyses.</p><p><strong>Results: </strong>25,625 adult hypertension patient pairs were included in the propensity score matched cohort. The median follow-up time was 180 days. Compared with patients receiving shorter-term prescriptions, lower hospitalization rates for cardiovascular diseases were observed in patients with longer-term prescriptions (hazard ratio: 0.88, 95 %CI: 0.80-0.98). The proportion of adherent patients in the longer-term group was higher than that in the shorter-term group (odds ratio: 1.91, 95 % CI: 1.84-1.98). The longer-term group also had fewer patients with ≥1 visit per month during the follow-up (odds ratio: 0.19, 95 %CI: 0.18-0.20). Subgroup and sensitive analysis showed consistent results.</p><p><strong>Conclusions: </strong>Longer-term prescriptions can improve patients' clinical outcomes and decrease their visit frequency. Promoting longer-term prescriptions can help mitigate the challenge of limited health resources and reduce disease burden.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.sapharm.2025.08.009","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Previous studies have shown that longer-term prescriptions could improve medication adherence of patients with chronic diseases. However, no evidence demonstrated the impact of a longer supply duration on patients' clinical outcomes. The objective is to estimate the association between longer-term prescriptions with patients' clinical outcomes.

Methods: A retrospective population-based propensity score-matched cohort study was conducted on the Chinese Electronic Health Records Research in Yinzhou database between January 2017 and June 2022. Prescriptions with the supply duration of antihypertensives >28 days were considered as longer-term prescriptions. The primary outcome was hospitalization for cardiovascular diseases. Secondary outcomes included medication adherence measured by medication possession ratio ≥80 % and visit frequency during the follow-up. Cox proportional hazard model and conditional logistic regression were used to estimate effects in the censored at treatment switch or discontinuation analyses.

Results: 25,625 adult hypertension patient pairs were included in the propensity score matched cohort. The median follow-up time was 180 days. Compared with patients receiving shorter-term prescriptions, lower hospitalization rates for cardiovascular diseases were observed in patients with longer-term prescriptions (hazard ratio: 0.88, 95 %CI: 0.80-0.98). The proportion of adherent patients in the longer-term group was higher than that in the shorter-term group (odds ratio: 1.91, 95 % CI: 1.84-1.98). The longer-term group also had fewer patients with ≥1 visit per month during the follow-up (odds ratio: 0.19, 95 %CI: 0.18-0.20). Subgroup and sensitive analysis showed consistent results.

Conclusions: Longer-term prescriptions can improve patients' clinical outcomes and decrease their visit frequency. Promoting longer-term prescriptions can help mitigate the challenge of limited health resources and reduce disease burden.

高血压患者长期与短期抗高血压处方与临床结果的关联:一项基于人群的倾向评分匹配研究
先前的研究表明,长期处方可以提高慢性疾病患者的药物依从性。然而,没有证据表明较长的供应时间对患者临床结果的影响。目的是估计长期处方与患者临床结果之间的关系。方法:于2017年1月至2022年6月在鄞州中国电子健康档案研究数据库中进行回顾性人群倾向评分匹配队列研究。降压药供应持续时间为28天的处方为较长期处方。主要结局是因心血管疾病住院。次要结局包括药物依从性,以药物占有率≥80%和随访期间的就诊次数衡量。使用Cox比例风险模型和条件逻辑回归来估计治疗切换或停止分析的影响。结果:25,625对成年高血压患者被纳入倾向评分匹配队列。中位随访时间为180天。与接受短期处方的患者相比,长期处方患者心血管疾病住院率较低(风险比:0.88,95% CI: 0.80-0.98)。长期组患者坚持治疗的比例高于短期组(优势比:1.91,95% CI: 1.84 ~ 1.98)。长期组随访期间每月就诊≥1次的患者也较少(优势比:0.19,95% CI: 0.18-0.20)。亚组和敏感分析结果一致。结论:长期处方可以改善患者的临床效果,减少患者的就诊次数。推广长期处方有助于缓解卫生资源有限带来的挑战并减轻疾病负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Research in Social & Administrative Pharmacy
Research in Social & Administrative Pharmacy PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
7.20
自引率
10.30%
发文量
225
审稿时长
47 days
期刊介绍: Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信